Enliven Therapeutics expenses grow as R&D ramps up – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $14.05, but opened at $13.59. Enliven Therapeutics shares last traded at $13.52, with a volume of 2,402 shares traded. Enliven Therapeutics Stock Up 0.6 % The firm’s 50-day moving average is […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) major shareholder 5Am Partners Vi, Llc sold 197,500 shares of Enliven Therapeutics stock in a transaction dated Tuesday, September 26th. The stock was sold at an average price of $15.00, for a total value of $2,962,500.00. Following the completion of the sale, the insider now directly owns […]
Fmr LLC purchased a new stake in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) during the 1st quarter, HoldingsChannel reports. The firm purchased 3,163,482 shares of the company’s stock, valued at approximately $69,280,000. Fmr LLC owned 0.48% of Enliven Therapeutics as of its most recent SEC filing. Other hedge funds have also modified […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s share price fell 1.8% during mid-day trading on Tuesday after an insider sold shares in the company. The company traded as low as $16.08 and last traded at $16.08. 727 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 140,922 […]